Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 2Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 105Head & Neck 12Genitourinary 12Thoracic 11Breast 9Endocrine 8Gynecologic 4Tumor-Agnostic 3Sarcoma 3Other solid neoplasm 3NET 2Lymphoid 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Squamous Intraepithelial Lesions 1Ovarian Neoplasms 1HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Radiofrequency Ablation × Gynecologic × Clear all
NCT01970787 2017-02-06

AIN

Medtronic - MITG

Phase NA Completed
22 enrolled 6 charts
Gynecologic

HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions

NCT02189161 2016-07-14

A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia

Medtronic - MITG

Phase NA Completed
10 enrolled 6 charts
Gynecologic

Squamous Intraepithelial Lesions

NCT02487693 2016-02-23

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

The First People's Hospital of Changzhou

Phase 2 Active not recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms

NCT02490748 2016-02-23

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

The First People's Hospital of Changzhou

Phase 2 Active not recruiting
10 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡